Article 5JTB2 Amazon and Walmart try—again—to upend prescription drug prices

Amazon and Walmart try—again—to upend prescription drug prices

by
Tim De Chant
from Ars Technica - All content on (#5JTB2)
GettyImages-1031028962-800x533.jpg

Enlarge (credit: Getty | George Frey)

Amazon and Walmart are ramping up their efforts to grab market share in the $360 billion prescription drug market in the US.

Today, Amazon announced that Prime members can receive a six-month supply of several widely prescribed drugs, starting at $6. Many drugs are pricier but are still discounted relative to typical cash prices. And yesterday, Walmart said it would be adding new discounts of up to 85 percent on prescription drugs purchased through its Walmart+ RX service, with an average savings of about 65 percent.

The new announcements come as the retail behemoths have largely failed to disrupt the traditional pharmacy industry. Big names still dominate, with CVS and Walgreens topping the rankings by revenue. Walmart, which has a significant physical footprint for its pharmacies, comes in fifth.

Read 7 remaining paragraphs | Comments

index?i=X0g83rhFV34:lgwpZdFPWoc:V_sGLiPB index?i=X0g83rhFV34:lgwpZdFPWoc:F7zBnMyn index?d=qj6IDK7rITs index?d=yIl2AUoC8zA
External Content
Source RSS or Atom Feed
Feed Location http://feeds.arstechnica.com/arstechnica/index
Feed Title Ars Technica - All content
Feed Link https://arstechnica.com/
Reply 0 comments